<DOC>
	<DOCNO>NCT01888744</DOCNO>
	<brief_summary>The aim study define optimal ovarian stimulation protocol concern PGD reason plan randomize controlled trial ( RCT ) compare gonadotropin-releasing hormone ( GnRH ) agonist protocol versus GnRH antagonist protocol . The follicle stimulate hormone ( FSH ) preparation arm highly purify FSH ( Menopur® ) .</brief_summary>
	<brief_title>Preimplantation Genetic Diagnosis ( PGD ) With Gonadotropin-releasing Hormone ( GnRH ) Agonist Versus Antagonist</brief_title>
	<detailed_description>Patients randomize outpatient clinic two group .</detailed_description>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<mesh_term>Buserelin</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Prolactin Release-Inhibiting Factors</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Ganirelix</mesh_term>
	<criteria>≤ 39 year day oocyte retrieval BMI ≤ 29 cycle rank 1 menstrual cycle 2536 day PGD preimplantation genetic screening ( PGS ) request ICSI Single embryo transfer ( SET ) day 5 Polycystic Ovary Syndrome ( PCOS ) ( accord Rotterdam criterion ) Hormonal disturbance Endometriosis grade III IV</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Intracytoplasmic sperm injection ( ICSI )</keyword>
	<keyword>PGD</keyword>
	<keyword>GnrH agonist</keyword>
	<keyword>GnRH antagonist</keyword>
</DOC>